Reckitt Benckiser Group plc announced the appointment of Olivier Bohuon to the Board as a non-executive director, effective January 1, 2021. He will also join the Remuneration Committee on the same date. Mr. Bohuon was CEO of FTSE 100 medical devices company Smith & Nephew from 2011 to 2018. Prior to that role he served as CEO of healthcare, cosmetology and pharmaceutical company Laboratoires Pierre Fabre from 2010-2011. Before that he worked for Abbott Laboratories from 2003 to 2010, rising to corporate executive vice president and president of the pharmaceutical products division. Mr. Bohuon previously worked at GlaxoSmithKline plc for a number of years in positions of increasing seniority. Mr. Bohuon is a member of the supervisory board of Virbac SA, is Chairman of the Board of Directors of Leo Pharma in Denmark and serves on the Board of Takeda Pharmaceuticals in Japan. He also served on the Board of Smiths Industries from July 2018 to November 2020. Mr. Bohuon is a member of the National Pharmacy Academy and the Academy of Technologies. He became a Knight of the Legion of Honour in 2007.